The Scientist

» drug development and genetics & genomics

Most Recent

image: TS Picks: September 8, 2015

TS Picks: September 8, 2015

By | September 8, 2015

Pharma edition

0 Comments

image: Unexpectedly Wild

Unexpectedly Wild

By | September 1, 2015

Genomic analysis reveals pigs interbred with wild boars during domestication.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | September 1, 2015

Brain Storms, Orphan, Maize for the Gods, and Paranoid.

0 Comments

image: The Sounds of Silence

The Sounds of Silence

By | September 1, 2015

Science-based tinnitus therapeutics are finally coming into their own.

3 Comments

image: Hearing Help

Hearing Help

By | September 1, 2015

For decades, the only remedies for hearing loss were devices such as hearing aids or cochlear implants. Now, the first pharmaceutical treatments may be on the way.  

2 Comments

image: Opinion: Engineering the Epigenome

Opinion: Engineering the Epigenome

By , , and | August 26, 2015

The use of targetable chromatin modifiers has ushered in a new era of functional epigenomics.

1 Comment

image: Hope for Universal Flu Vax?

Hope for Universal Flu Vax?

By | August 26, 2015

Two studies point to the possibility that a single vaccine could protect against every strain of flu virus.

0 Comments

image: Novartis Buys Rights to GSK MS Drug for $1 Billion

Novartis Buys Rights to GSK MS Drug for $1 Billion

By | August 24, 2015

The multiple sclerosis treatment has yet to be tested in Phase 3 clinical trials.

0 Comments

image: Alphabet Announces Life Sciences

Alphabet Announces Life Sciences

By | August 24, 2015

Google’s parent company is launching a research-and-development project as a standalone firm.

0 Comments

image: Illumina, Investors Launch Consumer Genetics Firm

Illumina, Investors Launch Consumer Genetics Firm

By | August 19, 2015

With $100 million in initial funding, Helix aims to make personal genomics accessible.

1 Comment

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS